Seattle Cancer Consortium Breast SPORE
Photo from Fred Hutch Archive
The Seattle Cancer Consortium Breast SPORE brings together clinical and laboratory researchers from the Fred Hutchinson Cancer Research Center and the University of Washington with a mission to carry out strategic research in highly translational projects and to continually explore and develop novel directions and new investigators in breast cancer research.
The scientists in this SPORE are on the forefront of research in immunotherapy, tumor microenvironment, cell cycle regulation and genetics that is poised to revolutionize the way we think about and treat patients with breast cancer.
The National Institutes of Health (NIH) Specialized Programs of Research Excellence (SPORE) funds integrated programs that conduct a wide spectrum of research activities while also developing specialized shared resources core facilities, improved research model systems, and collaborative research projects with other institutions.
The SPORE program’s research is translational in nature and is focused upon knowledge of human biology stemming from research using cellular, molecular, structural, biochemical and genetic experimental approaches with the goal of a translational human endpoint within the grant’s project period. SPOREs also include programs to foster careers in translational research.